Chapter 1. Preface

1.1 Report Description and Scope
1.2 Research Scope
1.3 Research Methodology
1.3.1 Market Research Type
1.3.2 Market Research Methodology

Chapter 2. Executive Summary

2.1 Global Europe Precision Medicine Market, (2026 - 2035) (USD Billion)
2.2 Global Europe Precision Medicine Market: Snapshot

Chapter 3. Global Europe Precision Medicine Market - Industry Analysis

3.1 Europe Precision Medicine Market: Market Dynamics
3.2 Market Drivers
3.2.1 Expanding due to falling genomic sequencing costs, the rise of AI-driven biomarker discovery, supportive government programs like the Genome of Europe, and a growing regulatory push for targeted oncology and rare disease therapies.
3.3 Market Restraints
3.3.1 Restricted by high therapy costs, complex regulatory hurdles, data privacy fears, inconsistent reimbursement policies, and a shortage of specialized clinical expertise.
3.4 Market Opportunities
3.4.1 Expanding targeted biologics, developing robust biobank and genomic infrastructures, standardizing clinical guidelines, and implementing favorable reimbursement policies and integrated AI platforms to enhance clinical translation and patient participation.
3.5 Market Challenges
3.5.1 High costs, strict MDR/IVDR regulations, GDPR-related data friction, fragmented reimbursement policies, and a shortage of specialized bioinformatics talent.
3.6 Porter’s Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Technology
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End-User

Chapter 4. Global Europe Precision Medicine Market- Competitive Landscape

4.1 Company Market Share Analysis
4.1.1 Global Europe Precision Medicine Market: Company Market Share, 2025
4.2 Strategic Development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, collaborations, and joint ventures
4.2.4 Research and development and regional expansion
4.3 Price Trend Analysis

Chapter 5. Global Europe Precision Medicine Market - Technology Analysis

5.1 Global Europe Precision Medicine Market Overview: Technology
5.1.1 Global Europe Precision Medicine Market share, By Technology, 2025 and 2035
5.2 Gene Sequencing
5.2.1 Global Europe Precision Medicine Market by Gene Sequencing, 2026 - 2035 (USD Billion)
5.3 Big Data Analytics
5.3.1 Global Europe Precision Medicine Market by Big Data Analytics, 2026 - 2035 (USD Billion)
5.4 Drug Discovery
5.4.1 Global Europe Precision Medicine Market by Drug Discovery, 2026 - 2035 (USD Billion)
5.5 Companion Diagnostics
5.5.1 Global Europe Precision Medicine Market by Companion Diagnostics, 2026 - 2035 (USD Billion)
5.6 Bioinformatics
5.6.1 Global Europe Precision Medicine Market by Bioinformatics, 2026 - 2035 (USD Billion)
5.7 CRISPR
5.7.1 Global Europe Precision Medicine Market by CRISPR, 2026 - 2035 (USD Billion)
5.8 Artificial Intelligence
5.8.1 Global Europe Precision Medicine Market by Artificial Intelligence, 2026 - 2035 (USD Billion)
5.9 Molecular Diagnostics
5.9.1 Global Europe Precision Medicine Market by Molecular Diagnostics, 2026 - 2035 (USD Billion)
5.10 Pharmacogenomics
5.10.1 Global Europe Precision Medicine Market by Pharmacogenomics, 2026 - 2035 (USD Billion)
5.11 Next-Generation Sequencing
5.11.1 Global Europe Precision Medicine Market by Next-Generation Sequencing, 2026 - 2035 (USD Billion)

Chapter 6. Global Europe Precision Medicine Market - Application Analysis

6.1 Global Europe Precision Medicine Market Overview: Application
6.1.1 Global Europe Precision Medicine Market Share, By Application, 2025 and 2035
6.2 Oncology
6.2.1 Global Europe Precision Medicine Market by Oncology, 2026 - 2035 (USD Billion)
6.3 Neurology
6.3.1 Global Europe Precision Medicine Market by Neurology, 2026 - 2035 (USD Billion)
6.4 Cardiology
6.4.1 Global Europe Precision Medicine Market by Cardiology, 2026 - 2035 (USD Billion)
6.5 Infectious Diseases
6.5.1 Global Europe Precision Medicine Market by Infectious Diseases, 2026 - 2035 (USD Billion)
6.6 Immunology
6.6.1 Global Europe Precision Medicine Market by Immunology, 2026 - 2035 (USD Billion)
6.7 Rare Diseases
6.7.1 Global Europe Precision Medicine Market by Rare Diseases, 2026 - 2035 (USD Billion)
6.8 Respiratory
6.8.1 Global Europe Precision Medicine Market by Respiratory, 2026 - 2035 (USD Billion)
6.9 Endocrinology
6.9.1 Global Europe Precision Medicine Market by Endocrinology, 2026 - 2035 (USD Billion)
6.10 Gastroenterology
6.10.1 Global Europe Precision Medicine Market by Gastroenterology, 2026 - 2035 (USD Billion)
6.11 Hematology
6.11.1 Global Europe Precision Medicine Market by Hematology, 2026 - 2035 (USD Billion)

Chapter 7. Global Europe Precision Medicine Market - End-User Analysis

7.1 Global Europe Precision Medicine Market Overview: End-User
7.1.1 Global Europe Precision Medicine Market Share, By End-User, 2025 and 2035
7.2 Hospitals
7.2.1 Global Europe Precision Medicine Market by Hospitals, 2026 - 2035 (USD Billion)
7.3 Diagnostic Centers
7.3.1 Global Europe Precision Medicine Market by Diagnostic Centers, 2026 - 2035 (USD Billion)
7.4 Research & Academic Institutes
7.4.1 Global Europe Precision Medicine Market by Research & Academic Institutes, 2026 - 2035 (USD Billion)
7.5 Pharmaceutical Companies
7.5.1 Global Europe Precision Medicine Market by Pharmaceutical Companies, 2026 - 2035 (USD Billion)
7.6 Biotechnology Companies
7.6.1 Global Europe Precision Medicine Market by Biotechnology Companies, 2026 - 2035 (USD Billion)
7.7 Healthcare Providers
7.7.1 Global Europe Precision Medicine Market by Healthcare Providers, 2026 - 2035 (USD Billion)
7.8 Clinical Laboratories
7.8.1 Global Europe Precision Medicine Market by Clinical Laboratories, 2026 - 2035 (USD Billion)
7.9 Government Organizations
7.9.1 Global Europe Precision Medicine Market by Government Organizations, 2026 - 2035 (USD Billion)
7.10 Insurance Providers
7.10.1 Global Europe Precision Medicine Market by Insurance Providers, 2026 - 2035 (USD Billion)
7.11 Contract Research Organizations
7.11.1 Global Europe Precision Medicine Market by Contract Research Organizations, 2026 - 2035 (USD Billion)

Chapter 8. Europe Precision Medicine Market - Regional Analysis

8.1 Global Europe Precision Medicine Market Regional Overview
8.2 Global Europe Precision Medicine Market Share, by Region, 2025 & 2035 (USD Billion)
8.3 North America
8.3.1 North America Europe Precision Medicine Market, 2026 - 2035 (USD Billion)
8.3.1.1 North America Europe Precision Medicine Market, by Country, 2026 - 2035 (USD Billion)
8.3.2 North America Europe Precision Medicine Market, by Technology, 2026 - 2035
8.3.2.1 North America Europe Precision Medicine Market, by Technology, 2026 - 2035 (USD Billion)
8.3.3 North America Europe Precision Medicine Market, by Application, 2026 - 2035
8.3.3.1 North America Europe Precision Medicine Market, by Application, 2026 - 2035 (USD Billion)
8.3.4 North America Europe Precision Medicine Market, by End-User, 2026 - 2035
8.3.4.1 North America Europe Precision Medicine Market, by End-User, 2026 - 2035 (USD Billion)
8.4 Europe
8.4.1 Europe Europe Precision Medicine Market, 2026 - 2035 (USD Billion)
8.4.1.1 Europe Europe Precision Medicine Market, by Country, 2026 - 2035 (USD Billion)
8.4.2 Europe Europe Precision Medicine Market, by Technology, 2026 - 2035
8.4.2.1 Europe Europe Precision Medicine Market, by Technology, 2026 - 2035 (USD Billion)
8.4.3 Europe Europe Precision Medicine Market, by Application, 2026 - 2035
8.4.3.1 Europe Europe Precision Medicine Market, by Application, 2026 - 2035 (USD Billion)
8.4.4 Europe Europe Precision Medicine Market, by End-User, 2026 - 2035
8.4.4.1 Europe Europe Precision Medicine Market, by End-User, 2026 - 2035 (USD Billion)
8.5 Asia Pacific
8.5.1 Asia Pacific Europe Precision Medicine Market, 2026 - 2035 (USD Billion)
8.5.1.1 Asia Pacific Europe Precision Medicine Market, by Country, 2026 - 2035 (USD Billion)
8.5.2 Asia Pacific Europe Precision Medicine Market, by Technology, 2026 - 2035
8.5.2.1 Asia Pacific Europe Precision Medicine Market, by Technology, 2026 - 2035 (USD Billion)
8.5.3 Asia Pacific Europe Precision Medicine Market, by Application, 2026 - 2035
8.5.3.1 Asia Pacific Europe Precision Medicine Market, by Application, 2026 - 2035 (USD Billion)
8.5.4 Asia Pacific Europe Precision Medicine Market, by End-User, 2026 - 2035
8.5.4.1 Asia Pacific Europe Precision Medicine Market, by End-User, 2026 - 2035 (USD Billion)
8.6 Latin America
8.6.1 Latin America Europe Precision Medicine Market, 2026 - 2035 (USD Billion)
8.6.1.1 Latin America Europe Precision Medicine Market, by Country, 2026 - 2035 (USD Billion)
8.6.2 Latin America Europe Precision Medicine Market, by Technology, 2026 - 2035
8.6.2.1 Latin America Europe Precision Medicine Market, by Technology, 2026 - 2035 (USD Billion)
8.6.3 Latin America Europe Precision Medicine Market, by Application, 2026 - 2035
8.6.3.1 Latin America Europe Precision Medicine Market, by Application, 2026 - 2035 (USD Billion)
8.6.4 Latin America Europe Precision Medicine Market, by End-User, 2026 - 2035
8.6.4.1 Latin America Europe Precision Medicine Market, by End-User, 2026 - 2035 (USD Billion)
8.7 The Middle-East and Africa
8.7.1 The Middle-East and Africa Europe Precision Medicine Market, 2026 - 2035 (USD Billion)
8.7.1.1 The Middle-East and Africa Europe Precision Medicine Market, by Country, 2026 - 2035 (USD Billion)
8.7.2 The Middle-East and Africa Europe Precision Medicine Market, by Technology, 2026 - 2035
8.7.2.1 The Middle-East and Africa Europe Precision Medicine Market, by Technology, 2026 - 2035 (USD Billion)
8.7.3 The Middle-East and Africa Europe Precision Medicine Market, by Application, 2026 - 2035
8.7.3.1 The Middle-East and Africa Europe Precision Medicine Market, by Application, 2026 - 2035 (USD Billion)
8.7.4 The Middle-East and Africa Europe Precision Medicine Market, by End-User, 2026 - 2035
8.7.4.1 The Middle-East and Africa Europe Precision Medicine Market, by End-User, 2026 - 2035 (USD Billion)

Chapter 9. Company Profiles

9.1 Illumina, Inc
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Business Strategy
9.1.5 Recent Developments
9.2 GE Healthcare
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Business Strategy
9.2.5 Recent Developments
9.3 Abbott
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Business Strategy
9.3.5 Recent Developments
9.4 Danaher (Cepheid)
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Business Strategy
9.4.5 Recent Developments
9.5 Exact Sciences
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Business Strategy
9.5.5 Recent Developments
9.6 QIAGEN
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Business Strategy
9.6.5 Recent Developments
9.7 IBM
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Business Strategy
9.7.5 Recent Developments
9.8 Genentech
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Business Strategy
9.8.5 Recent Developments
9.9 Biogen
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Business Strategy
9.9.5 Recent Developments
9.10 Genelex
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Business Strategy
9.10.5 Recent Developments

Frequently Asked Questions

Europe precision medicine is a healthcare approach that tailors treatments based on individual genetic, environmental, and lifestyle factors to optimize outcomes and minimize side effects.

Key factors include declining sequencing costs, AI advancements, government initiatives, and increasing adoption of targeted therapies.

The market is projected to grow from approximately USD 171.2 billion in 2026 to USD 346.7 billion by 2035.

The CAGR is expected to be 8.1% during the forecast period.

Germany will contribute notably, holding around 27% of the market value due to advanced infrastructure and programs.

Major players include Illumina, Inc., GE Healthcare, Abbott, Danaher (Cepheid), Exact Sciences, QIAGEN, IBM, Genentech, Biogen, and Genelex.

The report provides comprehensive analysis including market size, forecasts, segmentation, dynamics, regional insights, key players, trends, and FAQs.

The value chain includes discovery, clinical implementation, therapeutic monitoring, genomic data integration, and treatment decision support.

Trends are shifting towards AI integration and preventive strategies, with consumers preferring personalized, data-driven treatments for better outcomes.

Regulatory factors include complex approval requirements and reimbursement policies, while ethical concerns involve data privacy and genetic discrimination.